Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Transplants due to hepatitis C have declined dramatically thanks to effective treatment.
Hepatitis B and C, non-alcoholic steatohepatitis (NASH) and alcohol-related liver disease are the main causes of liver cancer and cirrhosis.
Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.
But experts advise caution, as the drug may worsen other liver diseases, including viral hepatitis.
From fatty liver disease to cirrhosis to alcoholic hepatitis—here’s what you need to know.
The biggest increases in alcohol-related deaths are among middle-aged women, according to a new study.
Alcohol-related liver disease is now the main reason for liver transplantation in the United States. The reasons for this are fascinating.
NPR’s “Fresh Air” recently interviewed Joshua Mezrich, MD, about what it’s like to save lives as a transplant surgeon.
The greatest increase was among 50- to 69-year-olds.
Ending the week with summaries of research from the 2018 Liver Meeting. I cover hepatitis B vaccination, diet and alcoholic liver disease.
A recent study in BMJ asks: Why do so many young people have unhealthy drinking habits?
Latinos are less likely to receive lifesaving surgeries, while Blacks are more likely to die posttransplant, according to a new study.
Observing Alcohol Awareness Month with a look at alcoholic liver disease and drinking.
This finding is specific to those who do not have liver cancer.
This finding calls into question the importance of the one differentiation between alcoholic and non-alcoholic fatty liver disease.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.